Variant report
Variant | nsv508524 |
---|---|
Chromosome Location | chr8:115600528-115657841 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:115598053..115599853-chr8:115604312..115606791,3 | MCF-7 | breast: | |
2 | chr8:115648075..115653566-chr8:115653938..115656968,8 | MCF-7 | breast: | |
3 | chr8:115648075..115653566-chr8:115653938..115656968,8 | MCF-7 | breast: | |
4 | chr8:115611607..115613247-chr8:115625084..115626919,2 | K562 | blood: | |
5 | chr8:115611607..115613247-chr8:115625084..115626919,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185637784 | chr8:115601001-115601002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs72688154 | chr8:115601018-115601019 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs190103631 | chr8:115601031-115601032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529113968 | chr8:115601059-115601060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550592029 | chr8:115601070-115601071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569178546 | chr8:115601082-115601083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372734320 | chr8:115601199-115601200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533078648 | chr8:115601231-115601232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551757550 | chr8:115601263-115601264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566885481 | chr8:115601293-115601294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574199515 | chr8:115601297-115601298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534255688 | chr8:115601334-115601335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543169353 | chr8:115601358-115601359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555922437 | chr8:115601362-115601363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567740846 | chr8:115601385-115601386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140621 | chr8:115601414-115601415 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs140622 | chr8:115601419-115601420 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs140623 | chr8:115601454-115601455 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs202191605 | chr8:115601470-115601471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557297719 | chr8:115601471-115601472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376960165 | chr8:115601478-115601479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539918662 | chr8:115601485-115601486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561486316 | chr8:115601529-115601530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529075378 | chr8:115601565-115601566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564041147 | chr8:115601628-115601629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544347083 | chr8:115601632-115601633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562549356 | chr8:115601639-115601640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57618910 | chr8:115601640-115601641 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs527921842 | chr8:115601641-115601642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs58824123 | chr8:115601673-115601674 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs369139291 | chr8:115601751-115601752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560484211 | chr8:115601767-115601768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527719212 | chr8:115601803-115601804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181651347 | chr8:115601828-115601829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185368590 | chr8:115601831-115601832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74719570 | chr8:115601912-115601913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188720553 | chr8:115601950-115601951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571764843 | chr8:115601954-115601955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs180801601 | chr8:115601955-115601956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140007393 | chr8:115601974-115601975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149653886 | chr8:115602005-115602006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529621271 | chr8:115602040-115602041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372912816 | chr8:115602051-115602052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533588367 | chr8:115602059-115602060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145464475 | chr8:115602068-115602069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573639306 | chr8:115602190-115602191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543986587 | chr8:115602191-115602192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373365166 | chr8:115602218-115602219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562673574 | chr8:115602231-115602232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577939203 | chr8:115602240-115602241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115601000-115601800 | Enhancers | Dnd41 | blood |
2 | chr8:115601800-115604200 | Weak transcription | Dnd41 | blood |
3 | chr8:115604200-115606400 | Enhancers | Dnd41 | blood |
4 | chr8:115618000-115618400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr8:115619600-115620400 | Enhancers | Dnd41 | blood |
6 | chr8:115619800-115620000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr8:115619800-115620200 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr8:115621600-115622000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr8:115641600-115642000 | Enhancers | Fetal Lung | lung |
10 | chr8:115649000-115649600 | Active TSS | H9 Cell Line | embryonic stem cell |
11 | chr8:115649000-115649600 | Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr8:115649000-115649800 | Active TSS | HUES48 Cell Line | embryonic stem cell |
13 | chr8:115649000-115649800 | Active TSS | HUES64 Cell Line | embryonic stem cell |
14 | chr8:115649000-115650000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:115649000-115650000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
16 | chr8:115649200-115649600 | Active TSS | H1 Cell Line | embryonic stem cell |
17 | chr8:115649200-115649600 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
18 | chr8:115649200-115649600 | Active TSS | Hela-S3 | cervix |
19 | chr8:115649200-115649800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
20 | chr8:115649200-115649800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
21 | chr8:115649200-115649800 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
22 | chr8:115649800-115650200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
23 | chr8:115653600-115654000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
24 | chr8:115653600-115654600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
25 | chr8:115656800-115657400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr8:115657400-115661200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |